One‐stage implant in sacral neuromodulation for faecal incontinence – short‐term outcome from a prospective study
Colorectal Disease · 2024
DOI: 10.1111/codi.16936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2024. Verfasst von Jakob Duelund-Jakobsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pelvic Floor Unit, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Fecal Incontinence, Electric Stimulation Therapy, Quality of Life, Patient Satisfaction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Danish Agency for Science, Technology and Innovation.
Themen: Inkontinenz
Abstract (Originalsprache)
Aim
Sacral neuromodulation (SNM) is approved for the treatment of faecal incontinence (FI) in a two‐stage technique. With standardized implantation, approximately 90% of patients undergo successful Stage I operation and proceed to a permanent implant (Stage II). The aim of this work was to explore the feasibility of SNM as a one‐stage procedure and report the 24‐week efficacy.
Method
This study included patients diagnosed with idiopathic FI or FI due to an external anal sphincter defect ≤160° and one or more episodes of FI per week despite maximal conservative therapy. Patients were offered a one‐stage procedure if a motor response of the external anal sphincter was achieved in three or more poles with at least one at ≤1.5 mA at lead placement. Patients were followed for 24 weeks. Their evaluation included the Wexner/St Mark's Incontinence Score, Faecal Incontinence Quality of Life score (FIQoL), a visual analogue scale (VAS) for assessing patient satisfaction and a bowel habit diary.
Results
Seventy‐three patients with a median age of 60 years (interquartile range 50–69 years) completed this prospective study. Episodes of FI were significantly reduced at the 24‐week follow‐up, from 13 (8–23) at baseline to 2 (0–5) ( p ‐value = 0002). A ≥50% reduction in the number of FI episodes was achieved in 92% of participants. The Wexner score improved significantly from 16 (14–17) at baseline to 9 (5–13) ( p ‐value < 0.001), and the St Mark's score improved significantly from 18 (16–20) to 11 (7–16) ( p ‐value < 0.001). All domains in the FIQoL score and VAS for patient satisfaction improved significantly following the one‐stage procedure.
Conclusion
A one‐stage implantation procedure is feasible in selected patients with FI, significantly improving continence, quality of life and patient satisfaction after 24 weeks of follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pelvic Floor Unit, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Gastroenterological Surgery, National Advisory Board of Incontinence and Pelvic Floor Health of Norway, University Hospital of North Norway, Tromsoe, Norway.
- Department of Clinical Medicine, Arctic University of North Norway, Tromsoe, Norway.
- Department of Surgical and Medical Gastroenterology, Hvidovre University Hospital, Hvidovre, Denmark.
ORCID-Profile: Lilli Lundby
Förderung
- The Danish Agency for Science, Technology and Innovation
Zitieren
APA
Duelund-Jakobsen, J., Buntzen, S., Lundby, L., Laurberg, S., Sørensen, M., & Rydningen, M. (2024). One‐stage implant in sacral neuromodulation for faecal incontinence – short‐term outcome from a prospective study. Colorectal Disease. https://doi.org/10.1111/codi.16936
Vancouver
Duelund-Jakobsen J, Buntzen S, Lundby L, Laurberg S, Sørensen M, Rydningen M. One‐stage implant in sacral neuromodulation for faecal incontinence – short‐term outcome from a prospective study. Colorectal Disease. 2024. doi:10.1111/codi.16936
BibTeX
@article{DuelundJakobsen2024,
author = {Duelund-Jakobsen, Jakob and Buntzen, Steen and Lundby, Lilli and Laurberg, Søren and Sørensen, Michael and Rydningen, Mona},
title = {One‐stage implant in sacral neuromodulation for faecal incontinence – short‐term outcome from a prospective study},
journal = {Colorectal Disease},
year = {2024},
doi = {10.1111/codi.16936}
}
EUVIMED